Dmx-like protein 1 (DMXL1)

Dmx-like protein 1 (DMXL1) is an evolutionarily conserved large protein with an exceptionally high number of WD repeat motifs, suggesting a role as a regulatory scaffold in mediating protein-protein interactions critical for various cellular processes[1][2]. DMXL1 is primarily known for its function as an essential assembly factor of the vacuolar H+-ATPase (V-ATPase) holoenzyme, regulating organelle acidification, notably in lysosomes and the mammalian kidney[3][4]. DMXL1 dynamically relocates to lysosomes in response to TRPML1 (a lysosomal cation channel) activation, facilitating the recruitment and assembly of the V1 domain with the membrane-bound VO domain, which is required for lysosomal function and pH maintenance[3][4]. Its expression has been detected in many tissue types, including eye tissue, and alterations in its levels are implicated in the progression of gliomas, copy number variations in glaucoma, and are associated with complex phenotypes in certain chromosomal deletions[1]. No direct small-molecule drugs or modulators of DMXL1 have been described, and it is not considered a typical therapeutic target such as a receptor or enzyme, but rather as a scaffolding and regulatory factor for critical homeostatic processes[4]. Because DMXL1 is essential for viability (complete knockout in mice is embryonically lethal), it poses significant safety concerns for therapeutic intervention[4]. No drugs are currently known to directly target DMXL1, and there are no established mechanisms of action or clinically used biomarkers involving this protein. Its essential role in cell physiology suggests any pharmacological modulation would carry high toxicity risk.

Other names

Dmx-like 1DmX-like protein 1XL1X-like 1 proteindmX-like protein 1DMXL1